Skip to main content

Table 5 Isokinetic strength and endurance test responses pre and post 3 months

From: Potential Effects on Cardiorespiratory and Metabolic Status After a Concurrent Strength and Endurance Training Program in Diabetes Patients — a Randomized Controlled Trial

Variables

SG (N = 20)

CARTG (N = 21)

Time factor

Exercise factor

Interaction

Isokinetic strength test

Pre

Post

Pre

Post

   

Peak torque extension (N m)

145.3 ± 47.9

143 ± 42.2

135.5 ± 41

159.7 ± 47.7‡

0.82

0.002

<0.001

Peak torque flexion (N m)

74.8 ± 26.4

72.2 ± 24.3

72.1 ± 19.3

92 ± 24.1‡†

0.27

<0.001

<0.001

PT/BW extension (%)

174.6 ± 34.3

176.4 ± 23.3

167 ± 41.5

195.8 ± 43.6‡

0.63

0.002

0.004

PT/BW flexion (%)

92.4 ± 19.8

89.5 ± 19.1

87.9 ± 14.7

116 ± 30.1‡†

0.10

0.001

<0.001

AVG power extension (watts)

90 ± 28

92 ± 27.3

86.8 ± 27

110.6 ± 31.8‡

0.42

<0.001

<0.001

AVG power flexion (watts)

50.2 ± 21.2

50.3 ± 19.5

47.7 ± 14.2

66.5 ± 18.2‡†

0.25

<0.001

<0.001

Isokinetic endurance test

Total work extension (J)

2673.8 ± 960.3

2660.5 ± 895.2

2744 ± 783.8

3171.2 ± 1111.5

0.37

0.09

0.08

Total work flexion (J)

1325.2 ± 511.9

1343.2 ± 443.5

1340.3 ± 453.8

1685 ± 717.1‡†

0.33

0.03

0.05

  1. Data are reported as means ± SD. PT/BW peak torque/body weight, AVG average force along the vertical axis. P ≤ 0.05, ‡exercise group pre × exercise group post, †sedentary group post × exercise group post